143 mSIPS-dNLR identifies patients unlikely to respond to first-line pembrolizumab for advanced non-small cell lung cancer

Lung Cancer 2026

View at publisher
Authors: Benjamin Jia Liang Lim, Elliot Erskine, Nicholas Fethers, Jenny Lamb, Irfaan Mohangee, Karim Hussien El-Shakankery, Jack Leach, Barry J. A. Laird, Christina Lilley, Sally Clive, Colin Barrie, Jane L. Parry
+7 more Almudena Cascales, Michael S. Yule, Leo R. Brown, Marie Fallon, Joanna Bowden, Iain Phillips, Stares Mark
DOI: 10.1016/j.lungcan.2026.109092
Cited by: 0

Fields of Study & Subjects

Inflammatory Biomarkers in Disease Prognosis Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

Publication details

Journal / source
Lung Cancer
Volume
212
Pages
109092–109092
Publication date
1 February 2026
Language
EN